Latest News
See all →
ITM and Alpha-9 Oncology Enter Into Supply Agreement for Therapeutic Medical Radioisotope Actinium-225
Garching / Munich, Germany and VANCOUVER, British Columbia, April 24, 2025 - ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical…
Read more
Barbara Weber, M.D., Elected to ITM Supervisory Board
Garching / Munich, Germany, April 09, 2025 - ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced…
Read more
ITM Appoints Dr. Celine Wilke as Chief Medical Officer
- Experienced leader in radiopharmaceutical drug development, regulatory, and clinical strategies will advance ITM’s broad pipeline and clinical…
